Granted Patent
Utility
US 6,576,669
· Confirmation No. 6112
USE OF AN LTB4 ANTAGONIST FOR THE TREATMENT OR PREVENTION OF DISEASES CAUSED BY INCREASED EXPRESSION OF MUCIN GENES
Inventors
Ralf Anderskewitz
Laupheim, GERMANY
Christopher J. Montague Meade
Bingen, GERMANY
Franz Birke
Ingelheim, GERMANY
Hans Michael Jennewein
Wiesbaden, GERMANY
Birgit Jung
Schwabenheim, GERMANY
Attorneys & Agents of Record
Classification
USPC
514/637
A61K45/06
A61P11/12
A61P43/00
A61P1/18
Y02A50/30
A61P11/00
A61K31/155
A61K31/27
A61K2300/00
Prosecution
- Examiner
- WEDDINGTON, KEVIN E
- Art Unit
- 1614
- Customer No.
- 28501
- Docket No.
- 01-1181
- Confirmation No.
- 6112
Foreign Priority
0101128.7
·
2001-01-16
·
UNITED KINGDOM
Publication
- Pub. No.
- US20020137792A1
- Pub. Date
- 2002-09-26
Patent Term Adjustment
-19days
CHANGE OF NAME
Recorded 2005-02-07
CHANGE OF NAME
Recorded 2004-06-28
from
ANDERSKEWITZ, RALF,
JENNEWEIN, HANS MICHAEL,
MEADE, CHRISTOPHER J. MONTAGUE,
JUNG, BIRGIT,
BIRKE, FRANZ
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded 2002-03-14
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
- Patent No.
- US 6,576,669
- App. No.
- 10/050,409
- Filed
- 2002-01-16
- Granted
- 2003-06-10
- Pub. No.
- US20020137792A1
- Examiner
- WEDDINGTON, KEVIN E
- Art Unit
- 1614
- PTA
- -19 days
External Links